144 related articles for article (PubMed ID: 12118751)
21. Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach.
Galetta D; Cesario A; Margaritora S; Porziella V; Macis G; D'Angelillo RM; Trodella L; Sterzi S; Granone P
Ann Thorac Surg; 2003 Dec; 76(6):1802-8; discussion 1808-9. PubMed ID: 14667587
[TBL] [Abstract][Full Text] [Related]
22. Outcome of Patients With pN2 "Potentially Resectable" Nonsmall Cell Lung Cancer Who Underwent Surgery After Induction Chemotherapy.
Spaggiari L; Casiraghi M; Guarize J; Brambilla D; Petrella F; Maisonneuve P; De Marinis F
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):593-602. PubMed ID: 28043483
[TBL] [Abstract][Full Text] [Related]
23. Is lung cancer surgery justified in patients with direct mediastinal invasion?
Doddoli C; Rollet G; Thomas P; Ghez O; Serée Y; Giudicelli R; Fuentes P
Eur J Cardiothorac Surg; 2001 Aug; 20(2):339-43. PubMed ID: 11463554
[TBL] [Abstract][Full Text] [Related]
24. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.
Eberhardt W; Wilke H; Stamatis G; Stuschke M; Harstrick A; Menker H; Krause B; Müeller MR; Stahl M; Flasshove M; Budach V; Greschuchna D; Konietzko N; Sack H; Seeber S
J Clin Oncol; 1998 Feb; 16(2):622-34. PubMed ID: 9469351
[TBL] [Abstract][Full Text] [Related]
25. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
26. Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery.
Taylor NA; Liao ZX; Stevens C; Walsh G; Roth J; Putnam J; Fossella F; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):616-25. PubMed ID: 12788166
[TBL] [Abstract][Full Text] [Related]
27. Pre-operative chemotherapy for stage IIIa (N2) non-small cell lung cancer.
Chella A; Lucchi M; Ribechini A; Silvano G; Mussi A; Janni A; Angeletti CA
Eur J Surg Oncol; 1995 Aug; 21(4):393-7. PubMed ID: 7664906
[TBL] [Abstract][Full Text] [Related]
28. Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.
Kasprzyk M; Dyszkiewicz W; Piwkowski C; Brudlo M; Galecki B; Gabryel P; Gasiorowski L
Neoplasma; 2013; 60(1):62-7. PubMed ID: 23067218
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.
Strauss GM; Herndon JE; Sherman DD; Mathisen DJ; Carey RW; Choi NC; Rege VB; Modeas C; Green MR
J Clin Oncol; 1992 Aug; 10(8):1237-44. PubMed ID: 1321893
[TBL] [Abstract][Full Text] [Related]
30. Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?
Collaud S; Provost B; Besse B; Fabre D; Le Chevalier T; Mercier O; Mussot S; Fadel E
J Surg Oncol; 2018 Jun; 117(7):1570-1574. PubMed ID: 29573419
[TBL] [Abstract][Full Text] [Related]
31. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
32. Mediastinoscopy in patients with clinical stage I non-small cell lung cancer.
Choi YS; Shim YM; Kim J; Kim K
Ann Thorac Surg; 2003 Feb; 75(2):364-6. PubMed ID: 12607640
[TBL] [Abstract][Full Text] [Related]
33. A novel histopathological evaluation method predicting the outcome of non-small cell lung cancer treated by neoadjuvant therapy: the prognostic importance of the area of residual tumor.
Yamane Y; Ishii G; Goto K; Kojima M; Nakao M; Shimada Y; Nishiwaki Y; Nagai K; Kohrogi H; Ochiai A
J Thorac Oncol; 2010 Jan; 5(1):49-55. PubMed ID: 20035185
[TBL] [Abstract][Full Text] [Related]
34. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
[TBL] [Abstract][Full Text] [Related]
35. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
[TBL] [Abstract][Full Text] [Related]
36. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage III non-small cell lung cancer.
Grossi F; Pennucci MC; Serrano J; Frola C; Mereu C; Scolaro T; Ratto GB; Tixi L; Ardizzoni A
Anticancer Res; 2002; 22(6B):3519-24. PubMed ID: 12552949
[TBL] [Abstract][Full Text] [Related]
38. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of the treatment (neoadjuvant chemotherapy and surgery) in IIb and IIIa stages of non-small cell lung cancer].
Ptaszek B; Chabowski M; Wiatr E; Orłowski TM; Langfort R; Bestry I; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2006; 74(2):171-8. PubMed ID: 17269365
[TBL] [Abstract][Full Text] [Related]
40. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
